Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Candidate gene approach for pharmacogenetic studies.

Huijun Z Ring1, Deanna L Kroetz

  • 1Incyte Genomics, Inc., 3174 Porter Drive, Palo Alto, California 94304, USA. huijun1@yahoo.com

Pharmacogenomics
|April 23, 2002
PubMed
Summary

Genetic diversity, including single nucleotide DNA polymorphisms (SNPs), impacts disease risk and drug response. Candidate gene studies, enhanced by genomics, identify genes for personalized medicine and improved drug development.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Barriers and facilitators to healthcare access for refugee, immigrant, and migrant populations during the COVID-19 pandemic: an overview of reviews.

BMC health services research·2026
Same author

A Genomically Tailored Multiagent Precision Medicine Clinical Trial for Adults with Recurrent Glioblastoma.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Association of SULT2A1 Locus With Abiraterone Clearance in the Alliance A031201: Randomized Phase III Study of Enzalutamide Compared With Enzalutamide Plus Abiraterone for Metastatic Castration-Resistant Prostate Cancer.

Clinical and translational science·2025
Same author

Tissue-origin transcriptomic interactions as indicators of inflammatory aging and aging gene discovery.

Computers in biology and medicine·2025
Same author

Immune infiltrate populations within distinct tumor immune microenvironments predictive of immune checkpoint treatment outcome.

Scientific reports·2025
Same author

Modeling mechanisms of chemotherapy-induced peripheral neuropathy and chemotherapy transport using induced pluripotent stem cell-derived sensory neurons.

Neuropharmacology·2024

Area of Science:

  • Genomics
  • Pharmacogenetics
  • Molecular Biology

Background:

  • Genetic variations like single nucleotide DNA polymorphisms (SNPs) influence individual susceptibility to diseases and responses to medications.
  • The candidate gene approach is a key strategy for uncovering the genetic underpinnings of pharmacogenetic traits.
  • Recent advancements in genomic technologies have significantly amplified the power and scope of candidate gene studies.

Purpose of the Study:

  • To highlight the role of genetic diversity, specifically SNPs, in pharmacogenetics.
  • To discuss the impact of advanced genomic technologies on candidate gene identification.
  • To underscore the potential of candidate gene-based pharmacogenetic studies for revolutionizing drug development and personalized therapeutics.

Main Methods:

Related Experiment Videos

  • Utilizing high-throughput sequencing and SNP genotyping to analyze thousands of candidate genes.
  • Employing expression-based genomic technologies, including DNA microarrays and proteomics.
  • Integrating data from various genomic approaches to identify genes associated with drug efficacy and toxicity.

Main Results:

  • Genomic technologies enable the large-scale study of candidate genes.
  • Expression-based methods aid in understanding biological and pharmacological pathways.
  • Identification of specific genes influencing drug response and toxicity is facilitated.

Conclusions:

  • Candidate gene studies are crucial for understanding pharmacogenetic variation.
  • Advanced genomic tools enhance the identification of relevant genes.
  • These studies pave the way for optimized drug development, clinical trials, and genotype-tailored therapies.